Literature DB >> 26709417

A Mathematical Model of the Pathogenesis, Prevention, and Reversal of Type 2 Diabetes.

Joon Ha1, Leslie S Satin1, Arthur S Sherman1.   

Abstract

Type 2 diabetes (T2D) is generally thought to result from the combination of 2 metabolic defects, insulin resistance, which increases the level of insulin required to maintain glucose within the normal range, and failure of insulin-secreting pancreatic β-cells to compensate for the increased demand. We build on a mathematical model pioneered by Topp and colleagues to elucidate how compensation succeeds or fails. Their model added a layer of slow negative feedback to the classic insulin-glucose loop in the form of a slow, glucose-dependent birth and death law governing β-cell mass. We add to that model regulation of 2 aspects of β-cell function on intermediate time scales. The model quantifies the relative contributions of insulin action and insulin secretion defects to T2D and explains why prevention is easier than cure. The latter is a consequence of a threshold separating the normoglycemic and diabetic states (bistability), which also underlies the success of bariatric surgery and acute caloric restriction in rapidly reversing T2D. The threshold concept gives new insight into "Starling's Law of the Pancreas," whereby insulin secretion is higher for prediabetics and early diabetics than for normal individuals.

Entities:  

Mesh:

Year:  2015        PMID: 26709417      PMCID: PMC4733125          DOI: 10.1210/en.2015-1564

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  46 in total

Review 1.  Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell.

Authors:  John J Tyson; Katherine C Chen; Bela Novak
Journal:  Curr Opin Cell Biol       Date:  2003-04       Impact factor: 8.382

2.  Control of pancreatic β cell regeneration by glucose metabolism.

Authors:  Shay Porat; Noa Weinberg-Corem; Sharona Tornovsky-Babaey; Rachel Schyr-Ben-Haroush; Ayat Hija; Miri Stolovich-Rain; Daniela Dadon; Zvi Granot; Vered Ben-Hur; Peter White; Christophe A Girard; Rotem Karni; Klaus H Kaestner; Frances M Ashcroft; Mark A Magnuson; Ann Saada; Joseph Grimsby; Benjamin Glaser; Yuval Dor
Journal:  Cell Metab       Date:  2011-04-06       Impact factor: 27.287

3.  Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes.

Authors:  D Ross Laybutt; Mariela Glandt; Gang Xu; Yu Bai Ahn; Nitin Trivedi; Susan Bonner-Weir; Gordon C Weir
Journal:  J Biol Chem       Date:  2002-11-15       Impact factor: 5.157

Review 4.  Triggering and amplifying pathways of regulation of insulin secretion by glucose.

Authors:  J C Henquin
Journal:  Diabetes       Date:  2000-11       Impact factor: 9.461

5.  A model of beta-cell mass, insulin, and glucose kinetics: pathways to diabetes.

Authors:  B Topp; K Promislow; G deVries; R M Miura; D T Finegood
Journal:  J Theor Biol       Date:  2000-10-21       Impact factor: 2.691

6.  Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling.

Authors:  Stacey B Dula; Mladen Jecmenica; Runpei Wu; Pooya Jahanshahi; Gretchen M Verrilli; Jeffrey D Carter; Kenneth L Brayman; Craig S Nunemaker
Journal:  Cell Calcium       Date:  2010-08-25       Impact factor: 6.817

7.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

8.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

Authors:  Alexandra E Butler; Juliette Janson; Susan Bonner-Weir; Robert Ritzel; Robert A Rizza; Peter C Butler
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

9.  Sleeping islets and the relationship between β-cell mass and function.

Authors:  Gordon C Weir; Susan Bonner-Weir
Journal:  Diabetes       Date:  2011-08       Impact factor: 9.461

10.  A low-oxygenated subpopulation of pancreatic islets constitutes a functional reserve of endocrine cells.

Authors:  Richard Olsson; Per-Ola Carlsson
Journal:  Diabetes       Date:  2011-08       Impact factor: 9.461

View more
  27 in total

Review 1.  Dissipative structures in biological systems: bistability, oscillations, spatial patterns and waves.

Authors:  Albert Goldbeter
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2018-07-28       Impact factor: 4.226

2.  Reducing Glucokinase Activity Restores Endogenous Pulsatility and Enhances Insulin Secretion in Islets From db/db Mice.

Authors:  Ishrat Jahan; Kathryn L Corbin; Avery M Bogart; Nicholas B Whitticar; Christopher D Waters; Cara Schildmeyer; Nicholas W Vann; Hannah L West; Nathan C Law; Jeffrey S Wiseman; Craig S Nunemaker
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

3.  Type 2 diabetes: one disease, many pathways.

Authors:  Joon Ha; Arthur Sherman
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-07-14       Impact factor: 4.310

4.  Chronic Glucose Exposure Systematically Shifts the Oscillatory Threshold of Mouse Islets: Experimental Evidence for an Early Intrinsic Mechanism of Compensation for Hyperglycemia.

Authors:  Eric Glynn; Benjamin Thompson; Suryakiran Vadrevu; Shusheng Lu; Robert T Kennedy; Joon Ha; Arthur Sherman; Leslie S Satin
Journal:  Endocrinology       Date:  2015-12-23       Impact factor: 4.736

Review 5.  Mechanisms of the amplifying pathway of insulin secretion in the β cell.

Authors:  Michael A Kalwat; Melanie H Cobb
Journal:  Pharmacol Ther       Date:  2017-05-18       Impact factor: 12.310

6.  A glucose-dependent spatial patterning of exocytosis in human β-cells is disrupted in type 2 diabetes.

Authors:  Jianyang Fu; John Maringa Githaka; Xiaoqing Dai; Gregory Plummer; Kunimasa Suzuki; Aliya F Spigelman; Austin Bautista; Ryekjang Kim; Dafna Greitzer-Antes; Jocelyn E Manning Fox; Herbert Y Gaisano; Patrick E MacDonald
Journal:  JCI Insight       Date:  2019-05-14

7.  Time to glucose peak during an oral glucose tolerance test identifies prediabetes risk.

Authors:  Stephanie T Chung; Joon Ha; Anthony U Onuzuruike; Kannan Kasturi; Mirella Galvan-De La Cruz; Brianna A Bingham; Rafeal L Baker; Jean N Utumatwishima; Lilian S Mabundo; Madia Ricks; Arthur S Sherman; Anne E Sumner
Journal:  Clin Endocrinol (Oxf)       Date:  2017-08-06       Impact factor: 3.478

8.  Islet Hypersensitivity to Glucose Is Associated With Disrupted Oscillations and Increased Impact of Proinflammatory Cytokines in Islets From Diabetes-Prone Male Mice.

Authors:  Kathryn L Corbin; Christopher D Waters; Brett K Shaffer; Gretchen M Verrilli; Craig S Nunemaker
Journal:  Endocrinology       Date:  2016-03-04       Impact factor: 4.736

9.  Biphasic dynamics of beta cell mass in a mouse model of congenital hyperinsulinism: implications for type 2 diabetes.

Authors:  Sharona Tornovsky-Babeay; Noa Weinberg-Corem; Rachel Ben-Haroush Schyr; Dana Avrahami; Judith Lavi; Eseye Feleke; Klaus H Kaestner; Yuval Dor; Benjamin Glaser
Journal:  Diabetologia       Date:  2021-02-09       Impact factor: 10.122

10.  When MINMOD Artifactually Interprets Strong Insulin Secretion as Weak Insulin Action.

Authors:  Joon Ha; Ranganath Muniyappa; Arthur S Sherman; Michael J Quon
Journal:  Front Physiol       Date:  2021-04-22       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.